Executive Leadership and Management Teams at Florida Cancer Specialists & Research Institute
Leaders in Cancer Care – We are proud of our tremendous track record and the momentum we are creating at the forefront of science and research. FCS remains successful in building the fundamental infrastructure that includes innovative technologies, the finest clinical experts and critical partnerships that will carry us far into the future. We are committed to providing world-class cancer care in community-based settings close to home.
Executive Leadership Team
View profile
Ken Sturtz
Chief Information & Administrative Officer
View profile
Paul Chadwick
Chief Value and Procurement Officer
View profile
Josh Eaves
Chief Development & Strategy Officer
Senior Management
View profile
Skip Boykin
Vice President, Enterprise Applications
View profile
Dawn Hackney
Vice President Financial Planning & Analysis
View profile
Trevor Heritage, Ph.D.
Senior Vice President & Data Officer
View profile
Tara Lambert, CPA
Vice President & Controller, Accounting
View profile
Sharon Lapkin, MS, RN, CPHRM
Vice President, Enterprise Risk Management
View profile
Colleen Lewis, MSN, ANP-BC, AOCNP
Vice President, Nursing and Research
View profile
Jon Meyers
Vice President, Physician Compensation
View profile
Chris Purdy, CPA, MBA
Vice President, Internal Audit & Process Controls
View profile
Nicole Radford, FACHE, MS, MT(ASCP)
Vice President, Laboratory Services
View profile
Frank Scimeca, PharmD, MBA, BCOP
Vice President, Pharmacy Services
View profile
Samantha Watkins
Vice President, Operations and Special Projects
View profile
Tonja A. Wise, CHC, CHPC, CCS
Vice President, Chief Compliance Officer
June 6, 2023
FCS Implements New Surface Guided Technology for Improved Radiation Therapy
June 1, 2023
The Impact of Genomic Profiling on Cancer Treatment: Insights from FCS President and Managing Physician
June 1, 2023
FCS Presents Cutting-Edge Clinical Research at 2023 ASCO® Annual Meeting
May 31, 2023
Advanced Molecular Genetic Testing and Clinical Trial Research Capabilities Improve Care Quality and Reduce Costs for Medicare Cancer Patients
